Rituximab Maintenance after First-Line Immunochemotherapy in Mantle Cell Lymphoma: Long-Term Follow-up of the Randomized European MCL Elderly Trial
暂无分享,去创建一个
W. Klapper | E. Hoster | W. Hiddemann | H. Tilly | H. Kluin-Nelemans | S. Stilgenbauer | M. André | M. Dreyling | C. Geisler | O. Hermine | V. Ribrag | J. Doorduijn | R. Forstpointner | M. Unterhalt | M. Trněný | J. Walewski | C. Thieblemont | L. Karlin | M. Szymczyk | U. Vehling‐Kaiser